Request Appointment
6560 Fannin StSte 802Houston, TX 77030
Fax+1 713-790-5079
Overview of Dr. Mokhtari
Dr. Sepideh Mokhtari is a neurologist in Houston, TX and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from Texas A&M; Health Science Center College of Medicine and has been in practice 11 years. She is one of 37 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Neurology. She has more than 20 publications and over 200 citings.
Education & Training
- Methodist Hospital (Houston)Residency, Neurology, 2011 - 2014
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2010 - 2011
- Texas A&M; Health Science Center College of MedicineClass of 2006
Certifications & Licensure
- FL State Medical License 2016 - 2027
- NY State Medical License 2014 - 2017
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
- Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease Start of enrollment: 2020 Dec 10
Publications & Presentations
PubMed
- NF2-associated schwannomatosis (NF2): genetics, manifestations, and emerging therapeutic approaches.Osama Elzaafarany, Daniel Lester, Sepideh Mokhtari, Joseph L Kissil
Trends in Molecular Medicine. 2025-08-29 - Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular Analyses.Yolanda Piña, Vincent Law, Solmaz Sahebjam, Nam Tran, Navya Siddarajappa
Neuro-Oncology. 2025-08-28 - Optic Pathway Glioma: Current Treatment Approaches and Ongoing Clinical Trials.Osama Elzaafarany, Sarah Elhomosany, Alexandra Rincones, Vincent Dlugi, Sepideh Mokhtari
Brain Sciences. 2025-08-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: